Saurin Chokshi is an Oncology physician affiliated with University of Tennessee Health Science Center. OpenAlex indexes 17 publications with 581 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
23 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
39.5%Opioid Agonist32.5%Oxycodone Hcl68%Oxycontin16%Oxycodone-Acetaminophen16%Part D<11 patientsPhenothiazine7%Prochlorperazine Maleate100%Part D<11 patientsCancer & immunology
37.3%PD-1 inhibitor12.3%Tecentriq100%Part D<11 patientsKinase inhibitor9.6%Imatinib Mesylate100%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
11.8%Serotonin-3 Receptor Antagonist6.6%Ondansetron Odt100%Part D<11 patientsPotassium supplement5.3%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Risk factors for early-onset colorectal cancer in the United States: An epidemiologic investigation.
Journal of Clinical Oncology
2026 - Case report of carcinoid syndrome with multi-organ involvement
Journal of Gastrointestinal Oncology
2025 - NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
Journal of the National Comprehensive Cancer Network
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Csaba Kovesdy, MD
University of Tennessee Health Science Center
David Shibata, MD
University of Tennessee Health Science Center
Helmut Steinberg, MD
University of Tennessee Health Science Center
Adam Arthur, MD
University of Tennessee Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”